Pelthos Therapeutics (PTHS) Amortizatization of Intangibles (2023 - 2026)
Pelthos Therapeutics (PTHS) posted quarterly Amortizatization of Intangibles of $109.0 for Q3 2025, down 98.95% year-over-year from $10370.0 in Q3 2024, and down 99.93% quarter-over-quarter from $164678.0 in Q2 2025.
Pelthos Therapeutics (PTHS) Amortizatization of Intangibles (2023 - 2026) Analysis & Trends
Pelthos Therapeutics' Amortizatization of Intangibles history runs 3 years deep, the most recent figure standing at $109.0 for Q3 2025.
- In Q3 2025, Amortizatization of Intangibles fell 98.95% year-over-year to $109.0; the TTM figure through Dec 2025 stood at $259000.0 (down 62.57% YoY), while the FY2025 annual figure was $259000.0, down 62.57% from the prior year.
- Amortizatization of Intangibles for Q3 2025 stood at $109.0, down from $164678.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $605630.0 in Q1 2024, with the low at $109.0 in Q3 2025.
- The 3-year median for Amortizatization of Intangibles is $53825.0 (2023), against an average of $113911.9.
- The sharpest annual moves came in 2024 and 2025: Amortizatization of Intangibles jumped 1813.52% in 2024, then sank 98.95% in 2025.
- Pelthos Therapeutics' Amortizatization of Intangibles stood at $121333.0 in 2023, then sank by 37.36% to $76000.0 in 2024, then tumbled by 99.86% to $109.0 in 2025.
- Business Quant data shows PTHS's Amortizatization of Intangibles at $109.0 in Q3 2025, $164678.0 in Q2 2025, and $94213.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 678,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Pelthos Therapeutics | 91.09 Mn | 66.53 Mn | 21.23 Mn | 2.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.04 Mn |
| Jun 30, 2026 | 2.04 Mn |
| Dec 31, 2025 | 1.08 Mn |
| Dec 31, 2025 | 1.08 Mn |
| Sep 30, 2025 | 109.00 |
| Sep 30, 2025 | 109.00 |
| Jun 30, 2025 | 164,678.00 |
| Jun 30, 2025 | 164,678.00 |
| Mar 31, 2025 | 94,213.00 |
| Mar 31, 2025 | 94,213.00 |
| Dec 31, 2024 | 76,000.00 |
| Dec 31, 2024 | 76,000.00 |
| Sep 30, 2024 | 10,370.00 |
| Sep 30, 2024 | 10,370.00 |
| Mar 31, 2024 | 605,630.00 |
| Mar 31, 2024 | 605,630.00 |
| Dec 31, 2023 | 121,333.00 |
| Dec 31, 2023 | 121,333.00 |
| Sep 30, 2023 | 17,664.00 |
| Sep 30, 2023 | 17,664.00 |